These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 34756674)

  • 1. Circulating high density lipoprotein distinguishes alcoholic hepatitis from heavy drinkers and predicts 90-day outcome: lipoproteins in alcoholic hepatitis.
    Mathur K; Vilar-Gomez E; Connelly MA; He H; Sanyal AJ; Chalasani N; Jiang ZG
    J Clin Lipidol; 2021; 15(6):805-813. PubMed ID: 34756674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating Extracellular Vesicles Carrying Sphingolipid Cargo for the Diagnosis and Dynamic Risk Profiling of Alcoholic Hepatitis.
    Sehrawat TS; Arab JP; Liu M; Amrollahi P; Wan M; Fan J; Nakao Y; Pose E; Navarro-Corcuera A; Dasgupta D; Liao CY; He L; Mauer AS; Avitabile E; Ventura-Cots M; Bataller RA; Sanyal AJ; Chalasani NP; Heimbach JK; Watt KD; Gores GJ; Gines P; Kamath PS; Simonetto DA; Hu TY; Shah VH; Malhi H
    Hepatology; 2021 Feb; 73(2):571-585. PubMed ID: 32246544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma lipoprotein composition in alcoholic hepatitis: accumulation of apolipoprotein E-rich high density lipoprotein and preferential reappearance of "light'-HDL during partial recovery.
    Weidman SW; Ragland JB; Sabesin SM
    J Lipid Res; 1982 May; 23(4):556-69. PubMed ID: 7097121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipoprotein Z, a hepatotoxic lipoprotein, predicts outcome in alcohol-associated hepatitis.
    Hu K; Perez-Matos MC; Argemi J; Vilar-Gomez E; Shalaurova I; Bullitt E; Landeen L; Sugahara G; Deng H; Mathur K; Tran S; Cai H; He H; Yalcin Y; Vieira Barbosa J; Ventura-Cots M; Marx K; Gad AP; Niezen S; Izunza Barba S; Ang LH; Popov YV; Fricker Z; Lai M; Curry M; Afdhal N; Szabo G; Mukamal KJ; Sanyal AJ; Otvos JD; Malik R; Saito T; Connelly MA; Chalasani NP; Bataller R; Jiang ZG
    Hepatology; 2022 Apr; 75(4):968-982. PubMed ID: 34662439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating concentrations of interleukin-18, interleukin-18 binding protein, and gamma interferon in patients with alcoholic hepatitis.
    Spahr L; Garcia I; Bresson-Hadni S; Rubbia-Brandt L; Guler R; Olleros M; Chvatchko Y; Hadengue A
    Liver Int; 2004 Dec; 24(6):582-7. PubMed ID: 15566508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Posttraumatic Stress Disorder in Patients with Heavy Alcohol Consumption and Alcoholic Hepatitis.
    Samala N; Lourens SG; Shah VH; Kamath PS; Sanyal AJ; Crabb DW; Tang Q; Radaeva S; Liangpunsakul S; Chalasani N
    Alcohol Clin Exp Res; 2018 Oct; 42(10):1933-1938. PubMed ID: 30080255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipoprotein particle profiles by nuclear magnetic resonance compared with standard lipids and apolipoproteins in predicting incident cardiovascular disease in women.
    Mora S; Otvos JD; Rifai N; Rosenson RS; Buring JE; Ridker PM
    Circulation; 2009 Feb; 119(7):931-9. PubMed ID: 19204302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipoprotein particle profiles compared with standard lipids in association with coronary artery calcification in the general Japanese population.
    Hisamatsu T; Fujiyoshi A; Miura K; Ohkubo T; Kadota A; Kadowaki S; Kadowaki T; Yamamoto T; Miyagawa N; Zaid M; Torii S; Takashima N; Murakami Y; Okamura T; Horie M; Ueshima H;
    Atherosclerosis; 2014 Oct; 236(2):237-43. PubMed ID: 25105580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Health-related quality of life is dynamic in alcoholic hepatitis and responds to improvement in liver disease and reduced alcohol consumption.
    Madathanapalli A; Tang Q; Lammert C; Samala N; Shah VH; Sanyal A; Chalasani N; Desai AP
    Alcohol Clin Exp Res; 2022 Feb; 46(2):252-261. PubMed ID: 34862610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The amount of alcohol consumption negatively impacts short-term mortality in Mexican patients with alcoholic hepatitis.
    Altamirano J; Higuera-de laTijera F; Duarte-Rojo A; Martínez-Vázquez MA; Abraldes JG; Herrera-Jiménez LE; Michelena J; Zapata L; Perez-Hernández J; Torre A; Gonzáles-González JA; Cardenas A; Dominguez M; Arroyo V; Ginès P; Caballería J; Bataller R
    Am J Gastroenterol; 2011 Aug; 106(8):1472-80. PubMed ID: 21556041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of obeticholic acid on the lipoprotein profile in patients with non-alcoholic steatohepatitis.
    Siddiqui MS; Van Natta ML; Connelly MA; Vuppalanchi R; Neuschwander-Tetri BA; Tonascia J; Guy C; Loomba R; Dasarathy S; Wattacheril J; Chalasani N; Sanyal AJ;
    J Hepatol; 2020 Jan; 72(1):25-33. PubMed ID: 31634532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood Biomarkers of Intestinal Epithelium Damage Regenerating Islet-derived Protein 3α and Trefoil Factor 3 Are Persistently Elevated in Patients with Alcoholic Hepatitis.
    Yang J; Syed F; Xia Y; Sanyal AJ; Shah VH; Chalasani N; Zheng X; Yu Q; Lou Y; Li W
    Alcohol Clin Exp Res; 2021 Apr; 45(4):720-731. PubMed ID: 33587293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of insulin resistance and type 2 diabetes on lipoprotein subclass particle size and concentration determined by nuclear magnetic resonance.
    Garvey WT; Kwon S; Zheng D; Shaughnessy S; Wallace P; Hutto A; Pugh K; Jenkins AJ; Klein RL; Liao Y
    Diabetes; 2003 Feb; 52(2):453-62. PubMed ID: 12540621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo evaluation of lipoprotein cholesterol ester metabolism in patients with liver disease.
    Monroe P; Vlahcevic ZR; Swell L
    Gastroenterology; 1983 Oct; 85(4):820-9. PubMed ID: 6884708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Changes in the levels of serum lipids and lipoprotein fractions of patients with acute alcoholic hepatitis].
    Vŭrbanov G; Mikhova V; Pateva R; Glinkova V
    Ter Arkh; 1988; 60(2):49-51. PubMed ID: 3368863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipoprotein Particle Profiles, Standard Lipids, and Peripheral Artery Disease Incidence.
    Aday AW; Lawler PR; Cook NR; Ridker PM; Mora S; Pradhan AD
    Circulation; 2018 Nov; 138(21):2330-2341. PubMed ID: 30021845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polydisperse low-density lipoproteins in hyperalphalipoproteinemic chronic alcohol drinkers in association with marked reduction of cholesteryl ester transfer protein activity.
    Hirano K; Matsuzawa Y; Sakai N; Hiraoka H; Nozaki S; Funahashi T; Yamashita S; Kubo M; Tarui S
    Metabolism; 1992 Dec; 41(12):1313-8. PubMed ID: 1461137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Model of disease severity in alcoholic hepatitis and novel prognostic insights.
    Enciu VT; Ologeanu PM; Călin-Necula AM; Moldoveanu AC; Oprea-Călin G; Fierbinţeanu-Braticevici C
    Rom J Intern Med; 2024 Jun; 62(2):194-202. PubMed ID: 38180800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term outcomes in patients with decompensated alcohol-related liver disease, steatohepatitis and Maddrey's discriminant function <32.
    Degré D; Stauber RE; Englebert G; Sarocchi F; Verset L; Rainer F; Spindelboeck W; Njimi H; Trépo E; Gustot T; Lackner C; Deltenre P; Moreno C
    J Hepatol; 2020 Apr; 72(4):636-642. PubMed ID: 31954208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of granulocyte colony stimulating factor in patients with severe alcoholic hepatitis with partial or null response to steroid (GRACIAH trial): study protocol for a randomized controlled trial.
    Cho Y; Park YS; Kim HY; Kim W; Lee HJ; Kim DJ
    Trials; 2018 Dec; 19(1):696. PubMed ID: 30577864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.